×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MURA – mural oncology plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
08:19 am
mura
Mural Oncology plc (NASDAQ: MURA) had its price target lowered by analysts at HC Wainwright from $18.00 to $6.00. They now have a "buy" rating on the stock.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) had its price target lowered by analysts at HC Wainwright from $18.00 to $6.00. They now have a "buy" rating on the stock.
3/25
01:06 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.
3/25
12:18 pm
mura
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $18.00 price target on the stock.
3/25
08:40 am
mura
Mural Oncology plc (NASDAQ: MURA) had its "hold" rating re-affirmed by analysts at Jones Trading.
High
Report
Mural Oncology plc (NASDAQ: MURA) had its "hold" rating re-affirmed by analysts at Jones Trading.
3/25
06:30 am
mura
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
High
Report
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
3/12
08:05 am
mura
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
3/11
04:01 pm
mura
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones
Low
Report
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones
2/18
07:00 am
mura
Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Medium
Report
Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/25
06:39 am
mura
Form 8-K Mural Oncology plc For: Mar 25
High
Report
Form 8-K Mural Oncology plc For: Mar 25
3/11
04:58 pm
mura
Form 8-K Mural Oncology plc For: Mar 11
Low
Report
Form 8-K Mural Oncology plc For: Mar 11
3/11
04:11 pm
mura
Form 10-K Mural Oncology plc For: Dec 31
Low
Report
Form 10-K Mural Oncology plc For: Dec 31
3/11
04:05 pm
mura
Form 8-K Mural Oncology plc For: Mar 11
Low
Report
Form 8-K Mural Oncology plc For: Mar 11
3/5
05:11 pm
mura
Form 144 Mural Oncology plc Filed by: Loew Caroline
Low
Report
Form 144 Mural Oncology plc Filed by: Loew Caroline
3/5
04:04 pm
mura
Form 144 Mural Oncology plc Filed by: Keson-Brookes Maiken
Low
Report
Form 144 Mural Oncology plc Filed by: Keson-Brookes Maiken
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: